Cover Image

Long-term benefits of EPs® 7630 in patients with acute sinusitis: a real-world cohort study

Background: We evaluated whether EPs® 7630 prescription in patients with acute sinusitis (AS) is associated with less frequent recurrence of AS, occurrence of chronic sinusitis or nasal polyps, or fewer antibiotic prescriptions.Methods: This retrospective cohort study used electronic medical records...

Full description

Saved in:

Bibliographic Details
Main Authors:	Matthias Tisch (Author), Lubomír Roháč (Author), Thorsten Reineke (Author), Martin Burkart (Author), Karel Kostev (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis
by: Wolfgang Kamin, et al.
Published: (2023)

Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs® 7630) in the Context of Health Promotion
by: Herbert Kolodziej
Published: (2011)

Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data
by: Fathi Abdul Malek, et al.
Published: (2024)

Faster recovery and reduced paracetamol use - a meta-analysis of EPs 7630 in children with acute respiratory tract infections
by: Georg Seifert, et al.
Published: (2019)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
by: Guy Scadding
Published: (2022)

Multiple mechanisms enable broad-spectrum activity of the Pelargonium sidoides root extract EPs 7630 against acute respiratory tract infections
by: Jindrich Cinatl, et al.
Published: (2024)

Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells
by: Jan Papies, et al.
Published: (2021)

Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study
by: Murat Sütçü, et al.
Published: (2024)

Corrigendum: Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells
by: Jan Papies, et al.
Published: (2021)

Up-Regulated Vitamin D Receptor by <i>Pelargonium sidoides</i> Extract EPs<sup>®</sup> 7630 Contributes to Rhinovirus Defense in Bronchial Epithelial Cells
by: Michael Roth, et al.
Published: (2021)

Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial
by: Tilman Keck, et al.
Published: (2021)

In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2
by: Jackson Emanuel, et al.
Published: (2023)

Investigation into the Effectiveness of an Herbal Combination (Angocin<sup>®</sup><i>Anti-Infekt N</i>) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort Study
by: Nina Kassner, et al.
Published: (2024)

The long-term impact of the COVID-19 pandemic on primary and specialized care provision and disease recognition in Germany
by: Moritz Platen, et al.
Published: (2022)

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
by: Tiago Torres, et al.
Published: (2024)

The COVID-19 Pandemic Enhanced the Decade-Long Trend of the Decreasing Utilization of Antibiotics
by: Christian Tanislav, et al.
Published: (2023)

A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
by: Emily K. Haque, et al.
Published: (2020)

Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function
by: Rachele Adorisio, et al.
Published: (2022)

Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience
by: Claudia Stefanutti, et al.
Published: (2022)

Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits
by: Arias-Mendoza A, et al.
Published: (2023)

Breastfeeding: Short and Long-Term Benefits to Baby and Mother
by: Wheeler, Ben
Published: (2020)

Short-Term Benefits, Long-Term Harm? Alternative Training to Apprenticeships in Norway
by: Tove Mogstad Aspøy, et al.
Published: (2017)

The relationship of PrEP beliefs to perceived personal, interpersonal and structural benefits and barriers to PrEP use in women who inject drugs
by: Kirsten Paulus, et al.
Published: (2023)

Long-term benefits of short North-South exchange visits
by: Karilyn J Collins, et al.
Published: (2015)

Long-term health benefits of appetite suppressants remain unproven
by: Francisco José Roma Paumgartten

Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results
by: María Luz Ruiz-Falcó Rojas, et al.
Published: (2022)

Real-World Data about Commonly Used Antibiotics in Long-Term Care Homes in Australia from 2016 to 2019
by: Chloé C. H. Smit, et al.
Published: (2023)

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
by: Claudia Fabiani, et al.
Published: (2019)

Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
by: Ting Zhao, et al.
Published: (2023)

Effectiveness of a Combination of Nasturtium Herb and Horseradish Root (Angocin<sup>®</sup> <i>Anti-Infekt N</i>) Compared to Antibiotics in Managing Acute and Recurrent Urinary Tract Infections: A Retrospective Real-world Cohort Study
by: Nina Kassner, et al.
Published: (2024)

Generalizability in real‐world trials
by: Anatol‐Fiete Näher, et al.
Published: (2024)

Pre-Exposure Prophylaxis (PrEP) Awareness Is Low Among Heterosexual People of Color Who Might Benefit From PrEP in Philadelphia
by: Alexis M. Roth, et al.
Published: (2019)

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
by: Teppei Hagino, et al.
Published: (2024)

Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice
by: Marin Kunimoto, et al.
Published: (2022)

A Retrospective Real-World Observational Study Assessing the Evolution of Bisacodyl Prescriptions in Patients with Constipation During Long-Term Treatment
by: Michel Bouchoucha, et al.
Published: (2023)

Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
by: Ahmet Hakan Ateş, et al.
Published: (2021)

The Dangers of Acetaminophen for Neurodevelopment Outweigh Scant Evidence for Long-Term Benefits
by: William Parker, et al.
Published: (2023)

Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions
by: Susan Baxter, et al.
Published: (2023)

Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry
by: Jan Hugo, et al.
Published: (2023)

Long-term outcomes of Absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
by: Sinem Çakal, et al.
Published: (2021)